1. A phase II study of omacetaxine mepesuccinate for patients with higher‐risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents. Issue 1 (15th November 2018) Authors: Short, Nicholas J.; Jabbour, Elias; Naqvi, Kiran; Patel, Ami; Ning, Jing; Sasaki, Koji; Nogueras‐Gonzalez, Graciela M.; Bose, Prithviraj; Kornblau, Steven M.; Takahashi, Koichi; Andreeff, Michael; Sanchez‐Petitto, Gabriela; Estrov, Zeev; Dinardo, Courtney D.; Montalban‐Bravo, Guillermo; Konopleva... Journal: American journal of hematology Issue: Volume 94:Issue 1(2019:Jan.) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗